IL111355A - Pharmaceutical preparations containing a history of aminoxoazoline, such new compounds and their preparation - Google Patents

Pharmaceutical preparations containing a history of aminoxoazoline, such new compounds and their preparation

Info

Publication number
IL111355A
IL111355A IL11135594A IL11135594A IL111355A IL 111355 A IL111355 A IL 111355A IL 11135594 A IL11135594 A IL 11135594A IL 11135594 A IL11135594 A IL 11135594A IL 111355 A IL111355 A IL 111355A
Authority
IL
Israel
Prior art keywords
chloro
signify
quinolin
alkyl
propane
Prior art date
Application number
IL11135594A
Other languages
English (en)
Hebrew (he)
Other versions
IL111355A0 (en
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL111355A0 publication Critical patent/IL111355A0/xx
Publication of IL111355A publication Critical patent/IL111355A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL11135594A 1993-10-28 1994-10-21 Pharmaceutical preparations containing a history of aminoxoazoline, such new compounds and their preparation IL111355A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH325593 1993-10-28

Publications (2)

Publication Number Publication Date
IL111355A0 IL111355A0 (en) 1994-12-29
IL111355A true IL111355A (en) 2001-11-25

Family

ID=4252022

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11135594A IL111355A (en) 1993-10-28 1994-10-21 Pharmaceutical preparations containing a history of aminoxoazoline, such new compounds and their preparation

Country Status (15)

Country Link
US (1) US5596002A (zh)
EP (1) EP0656353B1 (zh)
JP (1) JP2922122B2 (zh)
CN (2) CN1054124C (zh)
AT (1) ATE166868T1 (zh)
AU (1) AU696109B2 (zh)
CA (1) CA2133620A1 (zh)
DE (1) DE59406126D1 (zh)
DK (1) DK0656353T3 (zh)
ES (1) ES2118294T3 (zh)
IL (1) IL111355A (zh)
MY (1) MY113383A (zh)
NZ (1) NZ264763A (zh)
SG (1) SG47958A1 (zh)
ZA (1) ZA948305B (zh)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6168296A (en) * 1995-06-07 1996-12-30 The Administrators Of The Tulane Eductional Fund Chloroquine analogs and methods of preventing and treating p lasmodial disease
US6025359A (en) * 1996-06-17 2000-02-15 Eli Lilly And Company Drug resistance and multidrug resistance modulators
US5776939A (en) * 1997-06-12 1998-07-07 Eli Lilly And Company Drug resistance and multidrug resistance modulators
GB9904419D0 (en) * 1999-02-25 1999-04-21 Univ Liverpool 4-aminoquinolines
US20040229908A1 (en) * 1999-07-13 2004-11-18 Jodi Nelson Compositions and methods for the treatment of Parkinson's disease and tardive dyskinesias
ATE431141T1 (de) 1999-07-13 2009-05-15 Alpha Res Group Llc Zusammensetzungen und verfahren zur behandlung der parkinson-krankheit
US7217722B2 (en) 2000-02-01 2007-05-15 Kirin Beer Kabushiki Kaisha Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same
GB0012874D0 (en) * 2000-05-27 2000-07-19 Ufc Limited 4-Aminoquinolines
WO2002083641A2 (en) * 2001-04-17 2002-10-24 Actelion Pharmaceuticals Ltd. Amino-aza-cyclohexanes for the treatment of malaria
EP1474145B1 (en) * 2002-02-04 2008-04-23 F. Hoffmann-La Roche Ag Quinoline derivatives as npy antagonists
US7084157B2 (en) * 2002-05-17 2006-08-01 Rajeev Raut Ophthalmic pharmaceutical compositions and methods for treating ocular inflammation
US20060014786A1 (en) * 2002-05-17 2006-01-19 Rajeev Raut Opthalmic pharmaceutical compositions and methods for treating ocular inflammation
US6916627B2 (en) * 2002-11-27 2005-07-12 St. Jude Children's Research Hospital ATM kinase compositions and methods
US7108992B2 (en) * 2002-11-27 2006-09-19 St. Jude Children's Research Hospital ATM kinase compositions and methods
WO2006082030A1 (en) * 2005-02-04 2006-08-10 Ctg Pharma S.R.L. New 4-aminoquinoline derivatives as antimalarials
WO2006088541A2 (en) * 2005-02-17 2006-08-24 State Of Oregon Acting By & Through The State Board Of Higher Edu. On Behalf Of Portland State Unv. Quinoline derivatives and uses thereof
US8440695B2 (en) * 2005-11-09 2013-05-14 St Jude Children's Research Hospital Use of chloroquine to treat metabolic syndrome
FR2902100A1 (fr) * 2006-06-13 2007-12-14 Sanofi Aventis Sa Molecules duales contenant un derive peroxydique, leur synthese et leurs applications en therapeutique
US20080189982A1 (en) * 2007-02-09 2008-08-14 Krafsur Andrew B Shoe spring sole insert
US8481543B2 (en) 2008-11-18 2013-07-09 Oregon Health & Science University Compounds for treating parasitic disease
US20230416786A1 (en) 2020-11-30 2023-12-28 Cellectis Sa Use of aminoquinoline compounds for higher gene integration
CN115160296B (zh) * 2022-08-08 2024-05-28 西安市第五医院 一种n-取代喹啉-4-胺类化合物及其制备、药物组合物和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2594419A (en) * 1949-09-30 1952-04-29 Geschickter Fund Med Res Di-salicylate of 7-chloro-4-(4'-diethylamino-1'-methylbutylamino) quinoline
NL265777A (zh) * 1960-06-09
US3346579A (en) * 1966-04-25 1967-10-10 Squibb & Sons Inc Iodine chloride complexes of quinoline and acridine compounds
FR2498187A1 (fr) * 1981-01-16 1982-07-23 Rhone Poulenc Sante Procede de preparation d'amino-4 chloro-7 quinoleines
FR2612778B1 (fr) * 1987-03-24 1991-10-18 Ire Cell Targ Sa Nouveaux derives d'aminoquinoleine antimalarique, procede de preparation et composition pharmaceutique en contenant
JP3229883B2 (ja) * 1991-10-01 2001-11-19 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング フルオロベンゾニトリル類
US5510356A (en) * 1991-10-03 1996-04-23 University Of Nebraska Board Of Regents Bisquinolines and processes for their production and use to treat malaria

Also Published As

Publication number Publication date
CN1106389A (zh) 1995-08-09
US5596002A (en) 1997-01-21
IL111355A0 (en) 1994-12-29
AU696109B2 (en) 1998-09-03
AU7741994A (en) 1995-05-18
NZ264763A (en) 1997-10-24
JPH07188174A (ja) 1995-07-25
DK0656353T3 (da) 1999-02-01
MY113383A (en) 2002-02-28
ZA948305B (en) 1995-05-02
EP0656353B1 (de) 1998-06-03
DE59406126D1 (de) 1998-07-09
CN1130345C (zh) 2003-12-10
CN1245168A (zh) 2000-02-23
ATE166868T1 (de) 1998-06-15
JP2922122B2 (ja) 1999-07-19
SG47958A1 (en) 1998-04-17
EP0656353A1 (de) 1995-06-07
ES2118294T3 (es) 1998-09-16
CA2133620A1 (en) 1995-04-29
CN1054124C (zh) 2000-07-05

Similar Documents

Publication Publication Date Title
IL111355A (en) Pharmaceutical preparations containing a history of aminoxoazoline, such new compounds and their preparation
EP0765313B1 (en) N,n'-bis(quinolin-4-yl)-diamine derivatives, their preparation and their use as antimalarials
US20070129363A1 (en) N-type calcium channel antagonists for the treatment of pain
EP1339706B1 (en) N-type calcium channel antagonists for the treatment of pain
KR100263802B1 (ko) 항말라리아성 퀴놀린 유도체
US7153865B2 (en) N-type calcium channel antagonists for the treatment of pain
US4209519A (en) Anti-leishmanial lepidine derivatives
US6841680B2 (en) N-type calcium channel antagonists for the treatment of pain
US6906193B2 (en) N-type calcium channel antagonists for the treatment of pain
US7060834B2 (en) N-type calcium channel antagonists for the treatment of pain

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees